EU OKs Roche's Avastin for ovarian cancer
ZURICH (Reuters) - The European Commission has approved Roche's drug Avastin for treating women with newly diagnosed, advanced Ovarian Cancer, offering new options to sufferers previously limited to surgery and Chemotherapy. The Swiss drugmaker is the world's largest maker of Cancer Drugs. The EU's approval was granted for Avastin in combination with standard chemotherapy, it said in a statement on Friday. "Today's approval of Avastin marks the first major treatment advance in newly diagnosed ovarian cancer in 15 years," said Chief Medical Officer Hal Barron. ... read more..
No comments:
Post a Comment